MELISSA ZUBER: Open Payments
NPI 1174264295 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$297 in 12 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $297
Food & beverage: $297
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $78 |
| Otsuka America Pharmaceutical, Inc. | 2 | $60 |
| Janssen Pharmaceuticals, Inc | 2 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Biogen, Inc. | 1 | $28 |
| Amgen Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $18 |
Products named: VIVITROL, ABILIFY ASIMTUFII, SPRAVATO, CAPLYTA, ZURZUVAE, OTEZLA, VRAYLAR.
Industry payments across AZ — which companies pay providers there.
